PHAT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.10%

Insider Buying (Last 12 Months): $99,125.00

Insider Selling (Last 12 Months): $853,826.80

Phathom Pharmaceuticals Insider Trading History Chart

Phathom Pharmaceuticals Share Price & Price History

^$6.60

▼ -0.09 (-1.35%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Phathom Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/21/2025	Azmi Nabulsi	COO	Sell	7,886	$6.59	$51,968.74	233,390
1/21/2025	Molly Henderson	CFO	Sell	6,583	$6.59	$43,381.97	93,546
1/21/2025	Terrie Curran	Insider	Sell	19,109	$6.59	$125,928.31	360,465
12/19/2024	Azmi Nabulsi	COO	Sell	1,118	$8.00	$8,944.00	239,303
12/19/2024	Molly Henderson	CFO	Sell	1,291	$8.00	$10,328.00	98,156
12/13/2024	Frank Karbe	Director	Buy	12,500	$7.93	$99,125.00	57,000
7/15/2024	Azmi Nabulsi	COO	Sell	10,901	$11.72	$127,759.72	240,421
7/15/2024	Molly Henderson	CFO	Sell	4,325	$11.72	$50,689.00	99,447
7/15/2024	Terrie Curran	Insider	Sell	33,848	$11.72	$396,698.56	377,734
4/8/2024	Molly Henderson	CFO	Sell	3,435	$11.10	$38,128.50	95,263
3/22/2024	Terrie Curran	Insider	Sell	16,851	$9.11	$153,512.61	410,784
1/24/2024	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	3,703,703	$8.10	$29,999,994.30	3,755,583
1/19/2024	Molly Henderson	CFO	Sell	6,307	$7.75	$48,879.25	98,698
11/8/2023	Asit Parikh	Director	Buy	2,500	$7.80	$19,500.00	55,000
11/6/2023	Asit Parikh	Director	Buy	1,000	$8.04	$8,040.00	48,500
11/1/2023	Molly Henderson	CFO	Sell	12,492	$8.88	$110,928.96	105,188
6/2/2023	Molly Henderson	CFO	Sell	1,960	$11.41	$22,363.60	68,506
5/22/2023	Molly Henderson	CFO	Sell	2,110	$12.87	$27,155.70	70,466
4/11/2023	Azmi Nabulsi	COO	Buy	10,000	$8.26	$82,600.00	99,567
4/10/2023	Asit Parikh	Director	Buy	1,000	$7.55	$7,550.00	23,500
4/6/2023	Molly Henderson	CFO	Sell	3,439	$7.27	$25,001.53	72,576
4/6/2023	Terrie Curran	Insider	Buy	12,919	$7.82	$101,026.58	188,290
3/1/2023	Molly Henderson	CFO	Sell	2,032	$8.53	$17,332.96	76,015
3/1/2023	Terrie Curran	Insider	Sell	1,436	$8.54	$12,263.44	175,371
2/13/2023	Asit Parikh	Director	Buy	5,000	$7.73	$38,650.00	22,500
1/20/2023	Terrie Curran	Insider	Sell	5,821	$8.20	$47,732.20	176,807
1/12/2023	Asit Parikh	Director	Buy	5,000	$7.00	$35,000.00	17,500
5/16/2022	Azmi Nabulsi	COO	Buy	20,000	$8.16	$163,200.00	785,700
5/13/2022	Terrie Curran	Insider	Buy	20,500	$7.41	$151,905.00	64,595
5/12/2022	Asit Parikh	Director	Buy	12,500	$8.00	$100,000.00	12,500

See Full Table

SEC Filings (Institutional Ownership Changes) for Phathom Pharmaceuticals (NASDAQ:PHAT)

99.01% of Phathom Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Phathom Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	135,995	$1.10M	0.0%	-21.6%	0.195%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	117,803	$0.96M	0.0%	+20.2%	0.172%
2/17/2025	Woodline Partners LP	1,001,692	$8.13M	0.1%	-61.1%	1.465%
2/17/2025	Two Sigma Advisers LP	133,700	$1.09M	0.0%	N/A	0.196%
2/17/2025	Two Sigma Investments LP	485,790	$3.95M	0.0%	+215.4%	0.710%
2/17/2025	Tang Capital Management LLC	500,000	$4.06M	0.3%	N/A	0.731%
2/17/2025	Rafferty Asset Management LLC	11,113	$90K	0.0%	N/A	0.016%
2/17/2025	ProShare Advisors LLC	14,289	$0.12M	0.0%	+36.3%	0.021%
2/17/2025	Nuveen Asset Management LLC	147,523	$1.20M	0.0%	-4.4%	0.216%
2/17/2025	Numerai GP LLC	15,264	$0.12M	0.0%	-69.1%	0.022%
2/17/2025	Millennium Management LLC	59,991	$0.49M	0.0%	+82.2%	0.088%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	22,149	$0.18M	0.0%	+18.2%	0.032%
2/17/2025	Ensign Peak Advisors Inc	2,527,054	$20.52M	0.0%	-2.1%	3.696%
2/17/2025	Deutsche Bank AG	30,213	$0.25M	0.0%	+49.4%	0.044%
2/17/2025	Cubist Systematic Strategies LLC	282,553	$2.29M	0.0%	N/A	0.413%
2/17/2025	Catalys Pacific LLC	1,167,114	$9.48M	8.2%	+4.0%	1.707%
2/17/2025	Brevan Howard Capital Management LP	22,845	$0.19M	0.0%	N/A	0.033%
2/17/2025	Avidity Partners Management LP	1,390,100	$11.29M	1.1%	-23.0%	2.033%
2/17/2025	Bayesian Capital Management LP	14,900	$0.12M	0.0%	N/A	0.022%
2/17/2025	Bank of America Corp DE	166,505	$1.35M	0.0%	+60.4%	0.243%
2/17/2025	BNP Paribas Financial Markets	39,532	$0.32M	0.0%	N/A	0.058%
2/17/2025	683 Capital Management LLC	1,025,000	$8.32M	0.5%	+1.5%	1.499%
2/14/2025	Oracle Investment Management Inc.	145,064	$1.18M	0.6%	-84.6%	0.212%
2/14/2025	Northern Trust Corp	397,964	$3.23M	0.0%	+24.1%	0.582%
2/14/2025	Tudor Investment Corp ET AL	34,049	$0.28M	0.0%	-6.4%	0.050%
2/14/2025	Decheng Capital LLC	694,254	$5.64M	1.2%	-44.5%	1.015%
2/14/2025	Propel Bio Management LLC	989,927	$8.04M	8.0%	+13.8%	1.448%
2/14/2025	Virtus ETF Advisers LLC	43,789	$0.36M	0.1%	+45.6%	0.064%
2/14/2025	Gilder Gagnon Howe & Co. LLC	41,610	$0.34M	0.0%	-97.4%	0.061%
2/14/2025	Nebula Research & Development LLC	20,963	$0.17M	0.0%	N/A	0.031%
2/14/2025	Price T Rowe Associates Inc. MD	25,641	$0.21M	0.0%	+21.8%	0.037%
2/14/2025	Dark Forest Capital Management LP	32,029	$0.26M	0.0%	N/A	0.047%
2/14/2025	MetLife Investment Management LLC	24,366	$0.20M	0.0%	+28.0%	0.036%
2/13/2025	Canada Pension Plan Investment Board	15,400	$0.13M	0.0%	N/A	0.023%
2/13/2025	Marshall Wace LLP	98,068	$0.80M	0.0%	N/A	0.143%
2/13/2025	Wasatch Advisors LP	1,558,928	$12.66M	0.1%	+531.3%	2.280%
2/13/2025	Barclays PLC	76,463	$0.62M	0.0%	+32.3%	0.112%
2/13/2025	Summit Financial Wealth Advisors LLC	68,125	$0.55M	0.1%	+134.7%	0.100%
2/13/2025	Raymond James Financial Inc.	455,837	$3.70M	0.0%	N/A	0.667%
2/13/2025	Capula Management Ltd	16,083	$0.13M	0.0%	N/A	0.024%
2/13/2025	Invesco Ltd.	3,671,386	$29.81M	0.0%	-10.4%	5.369%
2/13/2025	Aristides Capital LLC	25,200	$0.21M	0.0%	N/A	0.037%
2/13/2025	Wells Fargo & Company MN	25,516	$0.21M	0.0%	+41.3%	0.037%
2/12/2025	Trexquant Investment LP	378,637	$3.08M	0.0%	N/A	0.554%
2/12/2025	Geode Capital Management LLC	1,018,495	$8.27M	0.0%	+18.0%	1.489%
2/12/2025	Alliancebernstein L.P.	45,590	$0.37M	0.0%	-9.0%	0.067%
2/12/2025	Wellington Management Group LLP	135,995	$1.10M	0.0%	-21.6%	0.199%
2/11/2025	Prudential Financial Inc.	463,340	$3.76M	0.0%	+11.6%	0.678%
2/11/2025	Vanguard Group Inc.	2,779,561	$22.57M	0.0%	+3.1%	4.065%
2/11/2025	Simplify Asset Management Inc.	581,935	$4.73M	0.2%	+11.5%	0.851%
2/11/2025	KLP Kapitalforvaltning AS	9,100	$74K	0.0%	N/A	0.013%
2/11/2025	Virtu Financial LLC	13,424	$0.11M	0.0%	N/A	0.020%
2/11/2025	Teacher Retirement System of Texas	11,065	$90K	0.0%	N/A	0.016%
2/10/2025	Commonwealth Equity Services LLC	50,772	$0.41M	0.0%	+387.7%	0.074%
2/6/2025	Raymond James Financial Inc.	455,837	$3.70M	0.0%	N/A	0.667%
2/6/2025	Keybank National Association OH	25,512	$0.21M	0.0%	+41.4%	0.037%
2/6/2025	Charles Schwab Investment Management Inc.	353,038	$2.87M	0.0%	+20.5%	0.516%
2/5/2025	Versor Investments LP	12,400	$0.10M	0.0%	N/A	0.018%
2/4/2025	Los Angeles Capital Management LLC	21,070	$0.17M	0.0%	N/A	0.031%
2/4/2025	Bank of New York Mellon Corp	102,748	$0.83M	0.0%	+4.6%	0.150%
1/30/2025	Allworth Financial LP	20,448	$0.17M	0.0%	-9.5%	0.030%
1/30/2025	Rhumbline Advisers	55,968	$0.45M	0.0%	+10.0%	0.082%
1/24/2025	Jennison Associates LLC	7,062,507	$57.35M	0.0%	+20.4%	10.328%
1/15/2025	Kera Capital Partners Inc.	26,849	$0.22M	0.1%	N/A	0.039%
1/15/2025	Inspirion Wealth Advisors LLC	19,964	$0.16M	0.0%	-45.5%	0.029%
11/19/2024	Barclays PLC	57,807	$1.04M	0.0%	+366.0%	0.085%
11/16/2024	Geode Capital Management LLC	862,918	$15.61M	0.0%	+7.1%	1.262%
11/15/2024	Barclays PLC	57,807	$1.04M	0.0%	+366.0%	0.085%
11/15/2024	MML Investors Services LLC	33,860	$0.61M	0.0%	+72.8%	0.050%
11/15/2024	Jane Street Group LLC	27,842	$0.50M	0.0%	-50.1%	0.041%
11/15/2024	Wellington Management Group LLP	173,383	$3.14M	0.0%	-23.5%	0.254%
11/15/2024	State Street Corp	922,788	$16.68M	0.0%	+17.5%	1.349%
11/15/2024	Point72 Asset Management L.P.	439,816	$7.95M	0.0%	N/A	0.643%
11/15/2024	Portolan Capital Management LLC	1,699,918	$30.74M	2.2%	+50.4%	2.486%
11/15/2024	Checkpoint Capital L.P.	1,504,307	$27.20M	13.5%	+71.9%	2.200%
11/14/2024	Wasatch Advisors LP	246,942	$4.47M	0.0%	N/A	0.361%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	98,025	$1.77M	0.0%	+5.2%	0.143%
11/13/2024	FMR LLC	1,304,114	$23.58M	0.0%	+49,000.7%	1.907%
11/13/2024	Summit Financial Wealth Advisors LLC	29,032	$0.53M	0.1%	N/A	0.042%
11/12/2024	Eagle Asset Management Inc.	455,196	$7.68M	0.0%	+25.9%	0.764%
11/12/2024	Charles Schwab Investment Management Inc.	292,860	$5.30M	0.0%	+2.4%	0.491%
11/9/2024	Intech Investment Management LLC	11,443	$0.21M	0.0%	N/A	0.019%
11/8/2024	Jennison Associates LLC	5,866,389	$106.06M	0.1%	+112.7%	9.845%
11/7/2024	Quest Partners LLC	10,918	$0.20M	0.0%	N/A	0.018%
11/6/2024	Huntington National Bank	1,471	$27K	0.0%	+62.2%	0.002%
11/5/2024	GSA Capital Partners LLP	15,083	$0.27M	0.0%	-48.7%	0.025%
11/4/2024	Chartwell Investment Partners LLC	21,904	$0.40M	0.0%	N/A	0.037%
10/28/2024	US Bancorp DE	5,248	$95K	0.0%	+28.6%	0.009%
10/25/2024	China Universal Asset Management Co. Ltd.	13,134	$0.24M	0.0%	+91.0%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,470	$43K	0.0%	+41.3%	0.004%
10/11/2024	Creative Planning	33,884	$0.61M	0.0%	+25.7%	0.057%
10/3/2024	SG Americas Securities LLC	13,483	$0.24M	0.0%	N/A	0.023%
8/16/2024	Creative Planning	26,951	$0.28M	0.0%	-16.0%	0.045%
8/15/2024	The Manufacturers Life Insurance Company	13,941	$0.14M	0.0%	+10.6%	0.023%
8/14/2024	Oracle Investment Management Inc.	225,000	$2.32M	2.2%	N/A	0.378%
8/14/2024	Marshall Wace LLP	112,691	$1.16M	0.0%	N/A	0.193%
8/13/2024	Ensign Peak Advisors Inc	2,244,828	$23.12M	0.0%	-1.5%	3.835%
8/1/2024	Rhumbline Advisers	55,178	$0.57M	0.0%	+17.1%	0.094%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,071	$0.10M	0.0%	+42.2%	0.017%
7/26/2024	Bank of New York Mellon Corp	114,721	$1.18M	0.0%	+20.5%	0.196%

Data available starting January 2016

See Full Table

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Today's Range

Now: $6.60

$6.35

$6.89

50 Day Range

MA: $5.85

$4.22

$7.17

52 Week Range

Now: $6.60

$4.07

$19.71

Volume

1,072,341 shs

Average Volume

985,727 shs

Market Capitalization

$459.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Who are the company insiders with the largest holdings of Phathom Pharmaceuticals?: Phathom Pharmaceuticals' top insider shareholders include:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Molly Henderson (CFO)
Frank Karbe (Director)
Asit Parikh (Director)
Learn More about top insider investors at Phathom Pharmaceuticals.
Who are the major institutional investors of Phathom Pharmaceuticals?: Phathom Pharmaceuticals' top institutional shareholders include:
Jennison Associates LLC — 10.33%
Invesco Ltd. — 5.37%
Vanguard Group Inc. — 4.07%
Ensign Peak Advisors Inc — 3.70%
Wasatch Advisors LP — 2.28%
Avidity Partners Management LP — 2.03%
Learn More about top institutional investors of Phathom Pharmaceuticals stock.
Which major investors are selling Phathom Pharmaceuticals stock?: Within the previous quarter, PHAT stock was sold by these institutional investors:
Gilder Gagnon Howe & Co. LLC
Woodline Partners LP
Oracle Investment Management Inc.
Decheng Capital LLC
Invesco Ltd.
Avidity Partners Management LP
Ensign Peak Advisors Inc
Wellington Management Group LLP
In the last year, company insiders that have sold Phathom Pharmaceuticals company stock include:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Learn More investors selling Phathom Pharmaceuticals stock.
Which major investors are buying Phathom Pharmaceuticals stock?: Within the previous quarter, PHAT stock was acquired by institutional investors including:
Wasatch Advisors LP
Jennison Associates LLC
Tang Capital Management LLC
Raymond James Financial Inc.
Raymond James Financial Inc.
Trexquant Investment LP
Two Sigma Investments LP
Jane Street Group LLC
During the last year, these company insiders have bought Phathom Pharmaceuticals stock:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Molly Henderson (CFO)
Learn More investors buying Phathom Pharmaceuticals stock.